9140 Evaluation of treatment adherence, persistance, and quality of life in patients with advanced non-small cell lung cancer (ANSCLC) treated with erlotinib (e) as second-line therapy
Keyword(s):
2012 ◽
Vol 20
(6)
◽
pp. 1941-1948
◽
Keyword(s):
2015 ◽
Vol 33
(5)
◽
pp. 522-523
◽
Keyword(s):
2012 ◽
Vol 28
(8)
◽
pp. 1253-1262
◽
Keyword(s):
2017 ◽
Vol 11
(6)
◽
pp. 469-479
◽
Keyword(s):
2019 ◽
Vol 14
(5)
◽
pp. 903-913
◽
Keyword(s):
Keyword(s):